Skip to main content

Parallel Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1690010 SAN FRANCISCO, CA

Position in REGN

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$855,312
+$87,302 QoQ
Shares Held
1,107
+11.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Parallel Advisors, LLC holds $172,911,965 across 172 Biotechnology names. REGN ranks #4 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 REGN
Regeneron Pharmaceuticals, Inc.
This page
1,107 $855,312

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $855,312 1,107
2025-12-31 $768,010 995
2025-09-30 $506,605 901
2025-06-30 $389,550 742
2025-03-31 $618,374 975
2024-12-31 $786,412 1,104
2024-09-30 $1,391,841 1,324
2024-06-30 $1,314,838 1,251
2024-03-31 $1,107,825 1,151
2023-12-31 $865,115 985
2023-09-30 $1,327,434 1,613
2023-06-30 $1,107,270 1,541
2023-03-31 $1,273,588 1,550
2022-12-31 $1,161,598 1,610
2022-09-30 $1,180,034 1,713
2022-06-30 $1,090,634 1,845
2022-03-31 $736,833 1,055
2021-12-31 $697,829 1,105
2021-09-30 $630,597 1,042
2021-06-30 $335,682 601
2021-03-31 $238,462 504
2020-12-31 $336,727 697
2020-09-30 $498,763 891
2020-06-30 $408,490 655
2020-03-31 $270,512 554